Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells (Q42510282)

1 November 2017

Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells (English)

1 reference

1 November 2017

Wei Jin

1

1 reference

1 November 2017

William R Reiley

2

1 reference

1 November 2017

Andrew J Lee

3

1 reference

1 November 2017

Ato Wright

4

1 reference

1 November 2017

Xuefeng Wu

5

1 reference

1 November 2017

Minying Zhang

6

1 reference

1 November 2017

Shao-Cong Sun

7

1 reference

1 November 2017

language of work or name

English

0 references

publication date

27 March 2007

1 reference

Journal of Biological Chemistry

1 November 2017

1 reference

1 November 2017

282

1 reference

1 November 2017

21

1 reference

1 November 2017

15884-15893

1 reference

Ubiquitin: structures, functions, mechanisms

1 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Ubiquitylation and cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Immunity by ubiquitylation: a reversible process of modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

A genomic and functional inventory of deubiquitinating enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Regulation of T cell development by the deubiquitinating enzyme CYLD

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Identification of the familial cylindromatosis tumour-suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Ubiquitin signalling in the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Negative regulation of JNK signaling by the tumor suppressor CYLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

NF-kappaB regulation in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Activation of NF-kappaB by HTLV-I and implications for cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

The role of BAFF in immune function and implications for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

IkappaB kinase is an essential component of the Tpl2 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Peripheral B-cell maturation: the intersection of selection and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Role of IL-6 and CD23 in the resistance to growth arrest and apoptosis in LCL41 B lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

CD86 and beta2-adrenergic receptor stimulation regulate B-cell activity cooperatively

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

The CD40-CD154 interaction in B cell-T cell liaisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Signaling in transitional type 2 B cells is critical for peripheral B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

Cutaneous appendage tumors: familial cylindromatosis and associated tumors update

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609952200

21 January 2018

Identifiers

DOI

10.1074/JBC.M609952200

1 reference

1 November 2017

1 reference